Effects of clinically relevant concentrations of glucosamine on equine chondrocytes and synoviocytes in vitro

American Journal of Veterinary Research

Volumn 69, Issue 9, 2008, Pages 1129-1134

  Byron, Christopher R ^a   Stewart, Matthew C ^a   Stewart, Allison A ^a   Pondenis, Holly C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYCLOOXYGENASE 2; GLUCOSAMINE; INTERLEUKIN 1; PROSTAGLANDIN E2; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARBOHYDRATE SYNTHESIS; CARTILAGE CELL; CELL FUNCTION; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG SYNOVIAL FLUID LEVEL; ENZYME SYNTHESIS; FATTY ACID SYNTHESIS; HORSE; IN VITRO STUDY; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; NONHUMAN; SYNOVIOCYTE;

ANIMALS; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; GLUCOSAMINE; HORSES; INTRAMOLECULAR OXIDOREDUCTASES; MATRIX METALLOPROTEINASE 13; PROTEOGLYCANS; SYNOVIAL MEMBRANE;

EQUIDAE;

EID: 52649149954     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.9.1129     Document Type: Article

References (32)

1. Jeffcott LB, Rossdale PD, Freestone J, et al. An assessment of wastage in Thoroughbred racing from conception to 4 years of age. Equine Vet J 1982;14:185-198.
2. Rossdale PD, Hopes R, Digby NJ, et al. Epidemiological study of wastage among racehorses, 1982 and 1983. Vet Rec 1985;116:66-69.
3. May SA, Lees P. Nonsteroidal anti-inflammatory drugs. In: Mc-Ilwraith CW, Trotter GW eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;223-236.
4. Blot L, Marcelis A, Devogelaer JP, et al. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacol 2000;131:1413-1421.
5. Chunekamrai S, Krook LP, Lust G, et al. Changes in articular cartilage after intra-articular injections of methylprednisolone acetate in horses. Am J Vet Res 1989;50:1733-1741.
6. Trotter GW, McIlwraith CW, Yovich JV, et al. Effects of intra-articular administration of methylprednisolone acetate on normal equine cartilage. Am J Vet Res 1991;52:83-87.
7. Shoemaker RS, Bertone AL, Martin GS, et al. Effects of intra-articular administration of methylprednisolone acetate on normal articular cartilage and on healing of experimentally induced osteochondral defects in horses. Am J Vet Res 1992;53:1446-1453.
8. Frisbie DD, Kawcak CE, Baxter GM, et al. Effects of 6α-methylprednisolone acetate on an equine osteochondral fragment exercise model. Am J Vet Res 1998;59:1619-1628.
9. Richardson DW, Loinaz R. An evidence-based approach to selected joint therapies in horses. Vet Clin North Am Equine Pract 2007;23:443-460.
10. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-1475.
11. Byron CR, Orth MW, Venta PJ, et al. Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulated equine chondrocytes. Am J Vet Res 2003;64:666-671.
12. Largo R, Alvarez-Soria A, Diez-Ortego I, et al. Glucosamine inhibits IL-1β-induced NFkB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003;11:290-298.
13. Fenton JI, Chlebek-Brown KA, Peters TL, et al. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 2000;8:258-265.
14. Gouze JN, Gouze E, Palmer GD, et al. Adenovirus-mediated gene transfer of glutamine:fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1β on rat chondrocytes. Osteoarthritis Cartilage 2004;12:217-224.
15. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998;6:427-434.
16. Chan PS, Caron JP, Orth MW, Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 2005;66:1870-1876.
17. Neil KM, Orth MW, Coussens PM, et al. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta. Am J Vet Res 2005;66:1861-1869.
18. Varghese S, Theprungsirikul P, Sahani S, et al. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage 2007;15:59-68.
19. Chan PS, Caron JP, Rosa GJ, et al. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants. Osteoarthritis Cartilage 2005;13:387-394.
20. Biggee BA, Blinn CM, McAlindon TE, et al. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis 2006;65:222-226.
21. Du J, White N, Eddington ND. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse. Biopharm Drug Dispos 2004;25:109-116.
22. Laverty S, Sandy JD, Celeste C, et al. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum 2005;52:181-191.
23. Theiler R, Ghosh P, Brooks P. Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming chondromodulating activity. Osteoarthritis Cartilage 1994;2:1-23.
24. 35S labeled proteoglyeans complexed to alcian blue by rapid filtration in multiwell plates. Anal Biochem 1994;217:167-175.
25. 35S-sulphate incorporation in bovine primary chondrocytes. Biochim Biophys Acta 2006;1762:453-459.
26. Chan PS, Caron JP, Orth MW. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. Am J Vet Res 2007;68:709-714.
27. Derfoul A, Miyoshi AD, Freeman DE, et al. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage 2007;15:646-655.
28. Nakamura H, Shibakawa A, Tanaka M, et al. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteinases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol 2004;22:293-299.
29. Lippiello L, Woodward J, Karpman R, et al. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res 2000;381:229-240.
30. De Mattei M, Pellati A, Pasello M, et al. High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 2002;10:816-825.
31. Gouze JN, Bianchi A, Bécuwe P, et al. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Lett 2002;510:166-170.
32. Scotto d'Abusco A, Calamia V, Cicione C, et al. Glucosamine affects intracellular signaling through inhibition of map kinase phosphorylation in human chondrocytes. Arthritis Res Ther 2007;9:R104.